[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5860 Received in Senate (RDS)]

<DOC>
118th CONGRESS
  1st Session
                                H. R. 5860


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

           September 30 (legislative day, September 22), 2023

                                Received

_______________________________________________________________________

                                 AN ACT


 
 Making continuing appropriations for fiscal year 2024, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Continuing Appropriations Act, 2024 
and Other Extensions Act''.

SEC. 2. TABLE OF CONTENTS.

    The table of contents of this Act is as follows:

Sec. 1. Short title.
Sec. 2. Table of contents.
Sec. 3. References.
            DIVISION A--CONTINUING APPROPRIATIONS ACT, 2024

                       DIVISION B--OTHER MATTERS

                 TITLE I--EXTENSIONS AND OTHER MATTERS

                        TITLE II--FAA EXTENSION

                  TITLE III--HEALTH AND HUMAN SERVICES

                      TITLE IV--BUDGETARY EFFECTS

SEC. 3. REFERENCES.

    Except as expressly provided otherwise, any reference to ``this 
Act'' contained in any division of this Act shall be treated as 
referring only to the provisions of that division.

            DIVISION A--CONTINUING APPROPRIATIONS ACT, 2024

     The following sums are hereby appropriated, out of any money in 
the Treasury not otherwise appropriated, and out of applicable 
corporate or other revenues, receipts, and funds, for the several 
departments, agencies, corporations, and other organizational units of 
Government for fiscal year 2024, and for other purposes, namely:
    Sec. 101.  Such amounts as may be necessary, at a rate for 
operations as provided in the applicable appropriations Acts for fiscal 
year 2023 and under the authority and conditions provided in such Acts, 
for continuing projects or activities (including the costs of direct 
loans and loan guarantees) that are not otherwise specifically provided 
for in this Act, that were conducted in fiscal year 2023, and for which 
appropriations, funds, or other authority were made available in the 
following appropriations Acts:
            (1) The Agriculture, Rural Development, Food and Drug 
        Administration, and Related Agencies Appropriations Act, 2023 
        (division A of Public Law 117-328), except section 729, and 
        including the matter under the headings ``Food for Peace Title 
        II Grants'' and ``McGovern-Dole International Food for 
        Education and Child Nutrition Program Grants'' in title I of 
        division M of Public Law 117-328, the matter under the headings 
        ``Agricultural Research Service--Buildings and Facilities'', 
        ``Food Safety and Inspection Service'', ``Rural Housing 
        Service-- Rural Community Facilities Program Account'' (except 
        all that follows after ``expended'' in such matter and except 
        that such matter shall be applied by substituting 
        ``$25,300,000'' for ``$75,300,000''), and ``Rural Utilities 
        Service--Rural Water and Waste Disposal Program Account'' 
        (except all that follows after ``expended'' in such matter and 
        except that such matter shall be applied by substituting 
        ``$60,000,000'' for ``$325,000,000'') in title I of division N 
        of Public Law 117-328, and section 2102 in title I of such 
        division N.
            (2) The Commerce, Justice, Science, and Related Agencies 
        Appropriations Act, 2023 (division B of Public Law 117-328), 
        except section 540, and except section 521(d)(1) shall be 
        applied by substituting ``$122,572,000'' for ``$705,768,000'', 
        and including the matter under the headings ``Federal Prison 
        System--Buildings and Facilities'' and ``National Science 
        Foundation--STEM Education'' (except all that follows after 
        ``2024'' in such matter and except that such matter shall be 
        applied by substituting ``$92,000,000'' for ``$217,000,000'') 
        in title II of division N of Public Law 117-328, and the second 
        paragraph under each of the headings ``National Oceanic and 
        Atmospheric Administration--Operations, Research, and 
        Facilities'' (except all that follows after ``2024'' in such 
        paragraph and except that such paragraph shall be applied by 
        substituting ``$42,000,000'' for ``$62,000,000''), ``National 
        Oceanic and Atmospheric Administration--Procurement, 
        Acquisition and Construction'', ``National Aeronautics and 
        Space Administration--Construction and Environmental Compliance 
        and Restoration'', and ``National Science Foundation--Research 
        and Related Activities'' (except all that follows after 
        ``2024'' in such paragraph and except that such paragraph shall 
        be applied by substituting ``$608,162,000'' for 
        ``$818,162,000'') in title II of such division N.
            (3) The Department of Defense Appropriations Act, 2023 
        (division C of Public Law 117-328).
            (4) The Energy and Water Development and Related Agencies 
        Appropriations Act, 2023 (division D of Public Law 117-328), 
        except the first proviso under the heading ``SPR Petroleum 
        Account'', and except the second paragraph under the heading 
        ``Title 17 Innovative Technology Loan Guarantee Program'', and 
        including the matter under the heading ``Energy Programs--
        Nuclear Energy'' in title III of division M of Public Law 117-
        328 and the second paragraph under each of the headings ``Corps 
        of Engineers--Civil--Department of the Army--Construction'' and 
        ``Corps of Engineers--Civil--Department of the Army--Operation 
        and Maintenance'' in title IV of division N of Public Law 117-
        328.
            (5) The Financial Services and General Government 
        Appropriations Act, 2023 (division E of Public Law 117-328).
            (6) The Department of Homeland Security Appropriations Act, 
        2023 (division F of Public Law 117-328), section 2602 of title 
        VI of division N of Public Law 117-328, and title III of 
        division O of Public Law 117-328.
            (7) The Department of the Interior, Environment, and 
        Related Agencies Appropriations Act, 2023 (division G of Public 
        Law 117-328), except section 443, and including the second 
        paragraph under each of the headings ``Department of the 
        Interior--Departmental Offices--Department-Wide Programs--
        Wildland Fire Management'' and ``Related Agencies--Department 
        of Agriculture--Forest Service--Wildland Fire Management'' in 
        title VII of division N of Public Law 117-328.
            (8) The Departments of Labor, Health and Human Services, 
        and Education, and Related Agencies Appropriations Act, 2023 
        (division H of Public Law 117-328), section 145 of division A 
        of Public Law 117-180, and the second paragraph under the 
        heading ``Administration for Children and Families--Low Income 
        Home Energy Assistance'' in title VIII of division N of Public 
        Law 117-328.
            (9) The Legislative Branch Appropriations Act, 2023 
        (division I of Public Law 117-328), and section 6 in the matter 
        preceding division A of Public Law 117-328.
            (10) The Military Construction, Veterans Affairs, and 
        Related Agencies Appropriations Act, 2023 (division J of Public 
        Law 117-328).
            (11) The Department of State, Foreign Operations, and 
        Related Programs Appropriations Act, 2023 (division K of Public 
        Law 117-328), except section 7069, and including the matter 
        under the headings ``Department of State--Administration of 
        Foreign Affairs--Diplomatic Programs'' (except all that follows 
        after ``2024'' in such matter and except that such matter shall 
        be applied by substituting ``$87,054,000'' for 
        ``$147,054,000''), ``Bilateral Economic Assistance--Funds 
        Appropriated to the President--International Disaster 
        Assistance'' (except all that follows after ``expended'' in 
        such matter and except that such matter shall be applied by 
        substituting ``$637,902,000'' for ``$937,902,000''), 
        ``Bilateral Economic Assistance--Funds Appropriated to the 
        President--Assistance for Europe, Eurasia and Central Asia'', 
        ``Bilateral Economic Assistance--Department of State--Migration 
        and Refugee Assistance'' (except all that follows after 
        ``expended'' in such matter and except that such matter shall 
        be applied by substituting ``$915,048,000'' for 
        ``$1,535,048,000''), and ``International Security Assistance--
        Department of State--International Narcotics Control and Law 
        Enforcement'' (except all that follows after ``2024'' in such 
        matter and except that such matter shall be applied by 
        substituting ``$74,996,000'' for ``$374,996,000'') in title VII 
        of division M of Public Law 117-328.
            (12) The Transportation, Housing and Urban Development, and 
        Related Agencies Appropriations Act, 2023 (division L of Public 
        Law 117-328), except sections 153 and 420, and including the 
        matter under the headings ``Public and Indian Housing-- Tenant-
        Based Rental Assistance'' and ``Housing Programs--Project-Based 
        Rental Assistance'' in title X of division N of Public Law 117-
        328.
    Sec. 102. (a) No appropriation or funds made available or authority 
granted pursuant to section 101 for the Department of Defense shall be 
used for:
            (1) the new production of items not funded for production 
        in fiscal year 2023 or prior years;
            (2) the increase in production rates above those sustained 
        with fiscal year 2023 funds; or
            (3) the initiation, resumption, or continuation of any 
        project, activity, operation, or organization (defined as any 
        project, subproject, activity, budget activity, program 
        element, and subprogram within a program element, and for any 
        investment items defined as a P-1 line item in a budget 
        activity within an appropriation account and an R-1 line item 
        that includes a program element and subprogram element within 
        an appropriation account) for which appropriations, funds, or 
        other authority were not available during fiscal year 2023.
    (b) No appropriation or funds made available or authority granted 
pursuant to section 101 for the Department of Defense shall be used to 
initiate multi-year procurements utilizing advance procurement funding 
for economic order quantity procurement unless specifically 
appropriated later.
    Sec. 103.  Appropriations made by section 101 shall be available to 
the extent and in the manner that would be provided by the pertinent 
appropriations Act.
    Sec. 104.  Except as otherwise provided in section 102, no 
appropriation or funds made available or authority granted pursuant to 
section 101 shall be used to initiate or resume any project or activity 
for which appropriations, funds, or other authority were not available 
during fiscal year 2023.
    Sec. 105.  Appropriations made and authority granted pursuant to 
this Act shall cover all obligations or expenditures incurred for any 
project or activity during the period for which funds or authority for 
such project or activity are available under this Act.
    Sec. 106.  Unless otherwise provided for in this Act or in the 
applicable appropriations Act for fiscal year 2024, appropriations and 
funds made available and authority granted pursuant to this Act shall 
be available until whichever of the following first occurs:
            (1) The enactment into law of an appropriation for any 
        project or activity provided for in this Act.
            (2) The enactment into law of the applicable appropriations 
        Act for fiscal year 2024 without any provision for such project 
        or activity.
            (3) November 17, 2023.
    Sec. 107.  Expenditures made pursuant to this Act shall be charged 
to the applicable appropriation, fund, or authorization whenever a bill 
in which such applicable appropriation, fund, or authorization is 
contained is enacted into law.
    Sec. 108.  Appropriations made and funds made available by or 
authority granted pursuant to this Act may be used without regard to 
the time limitations for submission and approval of apportionments set 
forth in section 1513 of title 31, United States Code, but nothing in 
this Act may be construed to waive any other provision of law governing 
the apportionment of funds.
    Sec. 109.  Notwithstanding any other provision of this Act, except 
section 106, for those programs that would otherwise have high initial 
rates of operation or complete distribution of appropriations at the 
beginning of fiscal year 2024 because of distributions of funding to 
States, foreign countries, grantees, or others, such high initial rates 
of operation or complete distribution shall not be made, and no grants 
shall be awarded for such programs funded by this Act that would 
impinge on final funding prerogatives.
    Sec. 110.  This Act shall be implemented so that only the most 
limited funding action of that permitted in the Act shall be taken in 
order to provide for continuation of projects and activities.
    Sec. 111. (a) For entitlements and other mandatory payments whose 
budget authority was provided in appropriations Acts for fiscal year 
2023, except the matter under the heading ``Cost of War Toxic Exposures 
Fund'' in title II of division J of Public Law 117-328, and for 
activities under the Food and Nutrition Act of 2008, activities shall 
be continued at the rate to maintain program levels under current law, 
under the authority and conditions provided in the applicable 
appropriations Act for fiscal year 2023, to be continued through the 
date specified in section 106(3).
    (b) Notwithstanding section 106, obligations for mandatory payments 
due on or about the first day of any month that begins after October 
2023 but not later than 30 days after the date specified in section 
106(3) may continue to be made, and funds shall be available for such 
payments.
    Sec. 112.  Amounts made available under section 101 for civilian 
personnel compensation and benefits in each department and agency may 
be apportioned up to the rate for operations necessary to avoid 
furloughs within such department or agency, consistent with the 
applicable appropriations Act for fiscal year 2023, except that such 
authority provided under this section shall not be used until after the 
department or agency has taken all necessary actions to reduce or defer 
non-personnel-related administrative expenses.
    Sec. 113.  Funds appropriated by this Act may be obligated and 
expended notwithstanding section 10 of Public Law 91-672 (22 U.S.C. 
2412), section 15 of the State Department Basic Authorities Act of 1956 
(22 U.S.C. 2680), section 313 of the Foreign Relations Authorization 
Act, Fiscal Years 1994 and 1995 (22 U.S.C. 6212), and section 504(a)(1) 
of the National Security Act of 1947 (50 U.S.C. 3094(a)(1)).
    Sec. 114. (a)(1) For each amount incorporated by reference in this 
Act from amounts provided by division M or N of Public Law 117-328, 
each section or paragraph of an account providing each such amount, as 
applicable, shall be applied as if that section or paragraph ended with 
the following sentence: ``The amount provided herein is designated by 
the Congress as an emergency requirement pursuant to section 
251(b)(2)(A)(i) of the Balanced Budget and Emergency Deficit Control 
Act of 1985.''.
    (2) Each amount incorporated by reference in this Act that was 
previously designated by the Congress as an emergency requirement 
pursuant to section 4001(a)(1) of S. Con. Res. 14 (117th Congress), the 
concurrent resolution on the budget for fiscal year 2022, and section 
1(e) of H. Res. 1151 (117th Congress), as engrossed in the House of 
Representatives on June 8, 2022, or as being for disaster relief 
pursuant to a concurrent resolution on the budget in the Senate and 
section 1(f) of H. Res. 1151 (117th Congress), as engrossed in the 
House of Representatives on June 8, 2022, is designated by the Congress 
as being an emergency requirement pursuant to section 251(b)(2)(A)(i) 
of the Balanced Budget and Emergency Deficit Control Act of 1985 or as 
being for disaster relief pursuant to section 251(b)(2)(D) of such Act, 
respectively.
    (b)(1) Each amount incorporated by reference in this Act that was 
specified to meet the terms of section 4004(b)(5)(B) of S. Con. Res. 14 
(117th Congress), the concurrent resolution on the budget for fiscal 
year 2022, and section 1(g)(2) of H. Res. 1151 (117th Congress), as 
engrossed in the House of Representatives on June 8, 2022, or as 
additional new budget authority for purposes of section 4004(b)(5) of 
such concurrent resolution and section 1(g) of such House resolution, 
is provided to meet the terms of section 251(b)(2)(F)(ii)(I) of the 
Balanced Budget and Emergency Deficit Control Act of 1985, or is 
additional new budget authority as specified for purposes of section 
251(b)(2)(F) of such Act, respectively.
    (2) Each amount incorporated by reference in this Act for 
``Department of Labor--Employment and Training Administration--State 
Unemployment Insurance and Employment Service Operations'' that was 
specified to meet the terms of a concurrent resolution on the budget in 
the Senate and section 1(j)(2) of H. Res. 1151 (117th Congress), as 
engrossed in the House of Representatives on June 8, 2022, or as 
additional new budget authority for purposes of a concurrent resolution 
on the budget in the Senate and section 1(j) of such House resolution, 
is provided to meet the terms of section 251(b)(2)(E)(ii) of the 
Balanced Budget and Emergency Deficit Control Act of 1985, or is 
additional new budget authority as specified for the purposes of 
section 251(b)(2)(E) of such Act, respectively.
    (3) Each amount incorporated by reference in this Act for 
``Department of Health and Human Services-- Centers for Medicare & 
Medicaid Services--Health Care Fraud and Abuse Control Account'' that 
was specified to meet the terms of a concurrent resolution on the 
budget in the Senate, or as additional new budget authority for 
purposes of a concurrent resolution on the budget in the Senate and 
section 1(h) of H. Res. 1151 (117th Congress), as engrossed in the 
House of Representatives on June 8, 2022, is provided to meet the terms 
of section 251(b)(2)(C)(ii) of the Balanced Budget and Emergency 
Deficit Control Act of 1985, or is additional new budget authority as 
specified for the purposes of section 251(b)(2)(C) of such Act, 
respectively.
    (4) Each amount incorporated by reference in this Act for ``Social 
Security Administration--Limitation on Administrative Expenses'' that 
was specified to meet the terms of a concurrent resolution on the 
budget in the Senate, or as additional new budget authority for 
purposes of a concurrent resolution on the budget in the Senate and 
section 1(i) of H. Res. 1151 (117th Congress), as engrossed in the 
House of Representatives on June 8, 2022, is provided to meet the terms 
of section 251(b)(2)(B)(ii)(III) of the Balanced Budget and Emergency 
Deficit Control Act of 1985, or is additional new budget authority as 
specified for the purposes of section 251(b)(2)(B) of such Act, 
respectively.
    (c) Each amount designated in this Act by the Congress as an 
emergency requirement pursuant to section 251(b)(2)(A)(i) of the 
Balanced Budget and Emergency Deficit Control Act of 1985 shall be 
available (or repurposed or rescinded, if applicable) only if the 
President subsequently so designates all such amounts and transmits 
such designations to the Congress.
    Sec. 115. (a) Rescissions or cancellations of discretionary budget 
authority that continue pursuant to section 101 in Treasury 
Appropriations Fund Symbols (TAFS)--
            (1) to which other appropriations are not provided by this 
        Act, but for which there is a current applicable TAFS that does 
        receive an appropriation in this Act; or
            (2) which are no-year TAFS and receive other appropriations 
        in this Act, may be continued instead by reducing the rate for 
        operations otherwise provided by section 101 for such current 
        applicable TAFS, as long as doing so does not impinge on the 
        final funding prerogatives of the Congress.
    (b) Rescissions or cancellations described in subsection (a) shall 
continue in an amount equal to the lesser of--
            (1) the amount specified for rescission or cancellation in 
        the applicable appropriations Act referenced in section 101 of 
        this Act; or
            (2) the amount of balances available, as of October 1, 
        2023, from the funds specified for rescission or cancellation 
        in the applicable appropriations Act referenced in section 101 
        of this Act.
    (c) No later than November 17, 2023, the Director of the Office of 
Management and Budget shall provide to the Committees on Appropriations 
of the House of Representatives and the Senate a comprehensive list of 
the rescissions or cancellations that will continue pursuant to section 
101: Provided, That the information in such comprehensive list shall be 
periodically updated to reflect any subsequent changes in the amount of 
balances available, as of October 1, 2023, from the funds specified for 
rescission or cancellation in the applicable appropriations Act 
referenced in section 101, and such updates shall be transmitted to the 
Committees on Appropriations of the House of Representatives and the 
Senate upon request.
    Sec. 116.  Amounts made available by section 101 for ``Farm Service 
Agency--Agricultural Credit Insurance Fund Program Account'' may be 
apportioned up to the rate for operations necessary to accommodate 
approved applications for direct and guaranteed farm ownership loans, 
as authorized by 7 U.S.C. 1922 et seq.
    Sec. 117.  Amounts made available by section 101 for ``Rural 
Housing Service--Rental Assistance Program'' may be apportioned up to 
the rate for operations necessary to maintain activities as authorized 
by section 521(a)(2) of the Housing Act of 1949.
    Sec. 118.  Amounts made available by section 101 for ``Domestic 
Food Programs--Food and Nutrition Service--Special Supplemental 
Nutrition Program for Women, Infants, and Children (WIC)'' may be 
apportioned at the rate for operations necessary to maintain 
participation.
    Sec. 119.  Amounts made available by section 101 for ``Domestic 
Food Programs--Food and Nutrition Service--Commodity Assistance 
Program'' may be apportioned up to the rate for operations necessary to 
maintain current program caseload in the Commodity Supplemental Food 
Program.
    Sec. 120.  Section 260 of the Agricultural Marketing Act of 1946 (7 
U.S.C. 1636i) and section 942 of the Livestock Mandatory Reporting Act 
of 1999 (7 U.S.C. 1635 note; Public Law 106-78) shall be applied by 
substituting the date specified in section 106(3) of this Act for 
``September 30, 2023''.
    Sec. 121.  Amounts made available by section 101 for ``National 
Telecommunications and Information Administration--Salaries and 
Expenses'' may be apportioned up to the rate for operations necessary 
to administer broadband programs.
    Sec. 122. (a) Funds previously made available in the Consolidated 
Appropriations Act, 2017 (Public Law 115-31) and the Consolidated 
Appropriations Act, 2018 (Public Law 115-141) under the heading 
``National Aeronautics and Space Administration--Space Operations'' 
that were available for obligation through fiscal year 2018 and fiscal 
year 2019, respectively, are to remain available through fiscal year 
2024 for the liquidation of valid obligations incurred in fiscal years 
2017 through 2019.
    (b)(1) Subject to paragraph (2), this section shall become 
effective immediately upon enactment of this Act.
    (2) If this Act is enacted after September 30, 2023, this section 
shall be applied as if it were in effect on September 30, 2023.
    Sec. 123.  For purposes of section 235(b) of the Sentencing Reform 
Act of 1984 (18 U.S.C. 3551 note; Public Law 98-473; 98 Stat. 2032), as 
such section relates to chapter 311 of title 18, United States Code, 
and the United States Parole Commission, each reference in such section 
to ``36 years'' or ``36-year period'' shall be deemed a reference to 
``36 years and 17 days'' or ``36-year and 17-day period'', 
respectively.
    Sec. 124.  Notwithstanding sections 102 and 104, amounts made 
available by section 101 to the Department of Defense for 
``Shipbuilding and Conversion, Navy'' may be apportioned up to the rate 
for operations necessary for ``Ohio Replacement Submarine (Full 
Funding)'' in an amount not to exceed $621,270,000 for the procurement 
of one Columbia Class Submarine.
    Sec. 125.  During the period covered by this Act, section 
714(b)(2)(B) of title 10, United States Code, shall be applied by 
substituting ``four years'' for ``two years''.
    Sec. 126.  Notwithstanding section 101, the matter preceding the 
first proviso under the heading ``Office of Personnel Management--
Salaries and Expenses'' in division E of Public Law 117-328 shall be 
applied by substituting ``$219,076,000'' for ``$190,784,000''.
    Sec. 127.  Notwithstanding any other provision of this Act, except 
section 106, the District of Columbia may expend local funds made 
available under the heading ``District of Columbia--District of 
Columbia Funds'' for such programs and activities under the District of 
Columbia Appropriations Act, 2023 (title IV of division E of Public Law 
117-328) at the rate set forth in the Fiscal Year 2024 Local Budget Act 
of 2023 (D.C. Act 25-161), as modified as of the date of enactment of 
this Act.
    Sec. 128.  Amounts made available by section 101 to the Department 
of Homeland Security under the heading ``Federal Emergency Management 
Agency--Disaster Relief Fund'' may be apportioned up to the rate for 
operations necessary to carry out response and recovery activities 
under the Robert T. Stafford Disaster Relief and Emergency Assistance 
Act (42 U.S.C. 5121 et seq.).
    Sec. 129.  In addition to amounts otherwise provided by section 
101, for ``Federal Emergency Management Agency--Disaster Relief Fund'', 
there is appropriated $16,000,000,000, for an additional amount for 
fiscal year 2024, to remain available until expended, of which 
$2,000,000 shall be transferred to ``Office of the Inspector General--
Operations and Support'' for audits and investigations of activities 
funded under ``Federal Emergency Management Agency--Disaster Relief 
Fund'' and $15,500,000,000 shall be for major disasters declared 
pursuant to the Robert T. Stafford Disaster Relief and Emergency 
Assistance Act (42 U.S.C. 5121 et seq.): Provided, That such amount is 
designated by the Congress as being for an emergency requirement 
pursuant to section 251(b)(2)(A)(i) of the Balanced Budget and 
Emergency Deficit Control Act of 1985.
    Sec. 130. (a) Sections 1309(a) and 1319 of the National Flood 
Insurance Act of 1968 (42 U.S.C. 4016(a) and 4026) shall be applied by 
substituting the date specified in section 106(3) of this Act for 
``September 30, 2023''.
    (b)(1) Subject to paragraph (2), this section shall become 
effective immediately upon enactment of this Act.
    (2) If this Act is enacted after September 30, 2023, this section 
shall be applied as if it were in effect on September 30, 2023.
    Sec. 131.  Section 227(a) of the Federal Cybersecurity Enhancement 
Act of 2015 (6 U.S.C. 1525(a)) shall be applied by substituting the 
date specified in section 106(3) of this Act for ``September 30, 
2023''.
    Sec. 132.  Amounts made available by section 101 for ``Department 
of the Interior--Department-Wide Programs--Wildland Fire Management'' 
and ``Department of Agriculture--Forest Service--Wildland Fire 
Management'' shall be available for the Federal wildland firefighter 
base salary increase provided under section 40803(d)(4)(B) of Public 
Law 117-58 and may be apportioned up to the rate for operations 
necessary to continue to fund such base salary increase.
    Sec. 133.  Activities authorized by part A of title IV (other than 
under section 403(c) or 418) and section 1108(b) of the Social Security 
Act shall continue through the date specified in section 106(3), in the 
manner authorized for fiscal year 2023, and out of any money in the 
Treasury of the United States not otherwise appropriated, there are 
hereby appropriated such sums as may be necessary for such purpose.
    Sec. 134.  Notwithstanding section 101, section 126 of division J 
of Public Law 117-328 shall be applied during the period covered by 
this Act by substituting ``fiscal year 2017, fiscal year 2018, and 
fiscal year 2019'' for ``fiscal year 2017 and fiscal year 2018''.
    Sec. 135.  The authority provided by section 2401 of the 
Afghanistan Supplemental Appropriations Act, 2022 (division C of Public 
Law 117-43) shall continue in effect through the date specified in 
section 106(3) of this Act.
    Sec. 136.  Notwithstanding section 101, the matter under the 
heading ``Bilateral Economic Assistance--Independent Agencies--
Millennium Challenge Corporation'' in title III of division K of Public 
Law 117-328 shall be applied by inserting the following new provisos 
before the last proviso: ``Provided further, That the member of the 
Board described in section 604(c)(3)(B)(ii) of the Millennium Challenge 
Act of 2003, as amended (22 U.S.C. 7703(c)(3)(B)(ii)), whose term began 
on September 16, 2019, shall continue to serve in such appointment 
until March 31, 2024: Provided further, That in the event that a new 
member of the Board described in section 604(c)(3)(B) of such Act (22 
U.S.C. 7703(c)(3)(B)) is appointed prior to March 31, 2024, the term of 
the member of the Board whose term began on September 16, 2019, shall 
terminate as of the date of such appointment:''.
    Sec. 137.  Notwithstanding section 101, the matter preceding the 
first proviso under the heading ``Department of Transportation--Federal 
Aviation Administration--Facilities and Equipment'' in title I of 
division L of Public Law 117-328 shall be applied by substituting 
``$617,000,000'' for ``$570,000,000'' and substituting 
``$2,174,200,000'' for ``$2,221,200,000''.

                       DIVISION B--OTHER MATTERS

                 TITLE I--EXTENSIONS AND OTHER MATTERS

SEC. 2101. EXTENSION OF CERTAIN PROVISIONS OF THE COMPACT OF FREE 
              ASSOCIATION WITH THE FEDERATED STATES OF MICRONESIA AND 
              THE FEDERAL PROGRAM AND SERVICES AGREEMENTS WITH THE 
              FEDERATED STATES OF MICRONESIA AND THE REPUBLIC OF THE 
              MARSHALL ISLANDS.

    (a) Grant and Other Financial Assistance.--
            (1) In general.--During the period beginning on October 1, 
        2023, and ending on November 17, 2023, any activities described 
        in sections 211, 212, and 215 of the Compact of Free 
        Association between the Government of the United States of 
        America and the Government of the Federated States of 
        Micronesia set forth in section 201(a) of the Compact of Free 
        Association Amendments Act of 2003 (48 U.S.C. 1921 note; Public 
        Law 108-188) shall, with the mutual consent of the Federated 
        States of Micronesia, continue in the manner authorized and 
        required for fiscal year 2023 under the agreements described in 
        paragraphs (4) and (5) of section 462(b) of that Compact.
            (2) Funding.--There is appropriated, out of any money in 
        the Treasury not otherwise appropriated, to carry out the 
        activities authorized under paragraph (1) an amount equal to 
        the pro rata portion of the amount appropriated for those 
        activities for fiscal year 2023.
    (b) Federal Programs and Services.--During the period beginning on 
October 1, 2023, and ending on the date on which a new Federal programs 
and services agreement with the applicable country enters into force, 
any activities described in sections 131, 132, and 221(a) of the 
Compact of Free Association between the Government of the United States 
of America and the Government of the Federated States of Micronesia set 
forth in section 201(a) of the Compact of Free Association Amendments 
Act of 2003 (48 U.S.C. 1921 note; Public Law 108-188) and sections 131, 
132, and 221(a) of the Compact of Free Association between the 
Government of the United States of America and the Government of the 
Republic of the Marshall Islands set forth in section 201(b) of that 
Act shall, with the mutual consent of the Federated States of 
Micronesia or the Republic of the Marshall Islands, as applicable, 
continue in the manner authorized and required for fiscal year 2023 
under the agreement described in section 462(b)(1) of the Compact of 
Free Association between the Government of the United States of America 
and the Government of the Federated States of Micronesia set forth in 
section 201(a) of that Act and the agreement described in section 
462(b)(1) of the Compact of Free Association between the Government of 
the United States of America and the Government of the Republic of the 
Marshall Islands set forth in section 201(b) of that Act, respectively.

SEC. 2102. EXTENSION OF DEADLINE TO PROMULGATE CERTAIN REGULATIONS.

    Section 413(a) of the Indian Self-Determination and Education 
Assistance Act (25 U.S.C. 5373(a)) is amended--
            (1) in paragraph (2), by striking ``21 months'' and 
        inserting ``38 months''; and
            (2) in paragraph (3), by striking ``30 months'' and 
        inserting ``50 months''.

                        TITLE II--FAA EXTENSION

                 Subtitle A--Federal Aviation Programs

SEC. 2201. AIRPORT IMPROVEMENT PROGRAM.

    (a) Authorization of Appropriations.--Section 48103(a) of title 49, 
United States Code, is amended--
            (1) in paragraph (5) by striking the ``and'' at the end;
            (2) in paragraph (6) by striking the period at the end and 
        inserting ``; and''; and
            (3) by adding at the end the following:
            ``(7) $842,076,502 for the period beginning on October 1, 
        2023, and ending on December 31, 2023.''.
    (b) Obligation Authority.--Subject to limitations specified in 
advance in appropriation Acts, sums made available pursuant to the 
amendment made by subsection (a) may be obligated at any time through 
September 30, 2024, and shall remain available until expended.
    (c) Program Implementation.--For purposes of calculating funding 
apportionments and meeting other requirements under sections 47114, 
47115, 47116, and 47117 of title 49, United States Code, for the period 
beginning on October 1, 2023, and ending on December 31, 2023, the 
Administrator of the Federal Aviation Administration shall--
            (1) first calculate such funding apportionments on an 
        annualized basis as if the total amount available under section 
        48103 of such title for fiscal year 2024 was $3,350,000,000; 
        and
            (2) then reduce by 75 percent--
                    (A) all funding apportionment amounts calculated 
                under paragraph (1); and
                    (B) amounts made available pursuant to subsections 
                (b) and (f)(2) of section 47117 of such title.
    (d) Extension of Project Grant Authority.--Section 47104(c) of 
title 49, United States Code, is amended in the matter preceding 
paragraph (1) by striking ``September 30, 2023,'' and inserting 
``December 31, 2023,''.
    (e) Extension of Special Rule for Apportionments.--Section 
47114(c)(1)(J) of title 49, United States Code, is amended by striking 
``2023 to'' and inserting ``2023, and for the period beginning on 
October 1, 2023, and ending on December 31, 2023, to''.

SEC. 2202. EXTENSION OF EXPIRING AUTHORITIES; MISCELLANEOUS 
              AUTHORIZATIONS.

    (a) Authority to Provide Insurance.--Section 44310(b) of title 49, 
United States Code, is amended by striking ``September 30, 2023'' and 
inserting ``December 31, 2023''.
    (b) Unmanned Aircraft Test Ranges.--Section 44803(h) of title 49, 
United States Code, is amended by striking ``September 30, 2023'' and 
inserting ``December 31, 2023''.
    (c) Special Authority for Certain Unmanned Aircraft Systems.--
Section 44807(d) of title 49, United States Code, is amended by 
striking ``September 30, 2023'' and inserting ``December 31, 2023''.
    (d) Extension of Airport Safety and Airspace Hazard Mitigation and 
Enforcement.--Section 44810(h) of title 49, United States Code, is 
amended by striking ``September 30, 2023'' and inserting ``December 31, 
2023''.
    (e) Competitive Access Reporting Requirement.--Section 47107(r)(3) 
of title 49, United States Code, is amended by striking ``October 1, 
2023'' and inserting ``January 1, 2024''.
    (f) Marshall Islands, Micronesia, and Palau.--Section 47115(i) of 
title 49, United States Code, is amended by inserting ``, and for the 
period beginning on October 1, 2023, and ending on December 31, 2023'' 
after ``fiscal years 2018 through 2023''.
    (g) Supplemental Discretionary Funds.--Section 47115(j)(4)(A) of 
title 49, United States Code, is amended by inserting at the end the 
following:
                            ``(vi) $140,401,803 for the period 
                        beginning on October 1, 2023, and ending on 
                        December 31, 2023.''.
    (h) Compatible Land Use Planning and Projects by State and Local 
Governments.--Section 47141(f) of title 49, United States Code, is 
amended by striking ``September 30, 2023'' and inserting ``December 31, 
2023''.
    (i) Non-movement Area Surveillance Pilot Program.--Section 47143(c) 
of title 49, United States Code, is amended by striking ``October 1, 
2023'' and inserting ``January 1, 2024''.
    (j) Weather Reporting Programs.--Section 48105 of title 49, United 
States Code, is amended by adding at the end the following:
            ``(5) $9,803,278 for the period beginning on October 1, 
        2023, and ending on December 31, 2023.''.
    (k) Learning Period.--Section 50905(c)(9) of title 51, United 
States Code, is amended by striking ``October 1, 2023'' and inserting 
``January 1, 2024''.
    (l) Midway Island Airport.--Section 186(d) of the Vision 100--
Century of Aviation Reauthorization Act (Public Law 108-176; 117 Stat. 
2518) is amended by inserting ``and for the period beginning on October 
1, 2023, and ending on December 31, 2023,'' after ``fiscal years 2018 
through 2023''.
    (m) Final Order Establishing Mileage and Adjustment Eligibility.--
Section 409(d) of the Vision 100--Century of Aviation Reauthorization 
Act (49 U.S.C. 41731 note) is amended by striking ``September 30, 
2023'' and inserting ``December 31, 2023''.
    (n) Contract Weather Observers.--Section 2306(b) of the FAA 
Extension, Safety, and Security Act of 2016 (Public Law 114-190; 130 
Stat. 641) is amended by striking ``October 1, 2023'' and inserting 
``January 1, 2024''.
    (o) Remote Tower Pilot Program.--Section 161(a)(10) of the FAA 
Reauthorization Act of 2018 (49 U.S.C. 47104 note) is amended by 
striking ``September 30, 2023'' and inserting ``December 31, 2023''.
    (p) Airport Access Roads in Remote Locations; Storage Facilities 
for Snow Removal Equipment.--Section 162 of the FAA Reauthorization Act 
of 2018 (49 U.S.C. 47102 note) is amended by inserting ``and for the 
period beginning on October 1, 2023, and ending on December 31, 2023'' 
after ``fiscal years 2018 through 2023''.
    (q) UAS Remote Detection and Identification Pilot Program.--Section 
372(d) of the FAA Reauthorization Act of 2018 (49 U.S.C. 44810 note) is 
amended by striking ``September 30, 2023'' and inserting ``December 31, 
2023''.
    (r) Advisory Committee for Aviation Consumer Protection.--Section 
411(h) of the FAA Modernization and Reform Act of 2012 (49 U.S.C. 42301 
note) is amended by striking ``September 30, 2023'' and inserting 
``December 31, 2023''.
    (s) Aviation Consumer Advocate.--Section 424(e) of the FAA 
Reauthorization Act of 2018 (49 U.S.C. 42302 note) is amended by 
striking ``September 30, 2023'' and inserting ``December 31, 2023''.
    (t) Advisory Committee on Air Travel Needs of Passengers With 
Disabilities.--Section 439(g) of the FAA Reauthorization Act of 2018 
(49 U.S.C. 41705 note) is amended by striking ``September 30, 2023'' 
and inserting ``December 31, 2023''.
    (u) Enhanced Traffic Services.--Section 547(e) of the FAA 
Reauthorization Act of 2018 (49 U.S.C. 40103 note) is amended by 
striking ``September 30, 2023'' and inserting ``December 31, 2023''.
    (v) Pilot Program for Redevelopment of Airport Properties.--Section 
822(k) of the FAA Modernization and Reform Act of 2012 (49 U.S.C. 47141 
note) is amended by striking ``September 30, 2023'' and inserting 
``December 31, 2023''.

SEC. 2203. FEDERAL AVIATION ADMINISTRATION OPERATIONS.

    Section 106(k) of title 49, United States Code, is amended--
            (1) in paragraph (1)--
                    (A) in subparagraph (E) by striking ``and'' at the 
                end;
                    (B) in subparagraph (F) by striking the period at 
                the end and inserting ``; and''; and
                    (C) by inserting after subparagraph (F) the 
                following:
                    ``(G) $2,995,027,322 for the period beginning on 
                October 1, 2023, and ending on December 31, 2023.''; 
                and
            (2) in paragraph (3) by inserting ``and for the period 
        beginning on October 1, 2023, and ending on December 31, 2023'' 
        after ``fiscal years 2018 through 2023''.

SEC. 2204. AIR NAVIGATION FACILITIES AND EQUIPMENT.

    Section 48101(a) of title 49, United States Code, is amended by 
adding at the end the following:
            ``(7) $740,273,224 for the period beginning on October 1, 
        2023, and ending on December 31, 2023.''.

SEC. 2205. RESEARCH, ENGINEERING, AND DEVELOPMENT.

    Section 48102(a) of title 49, United States Code, is amended--
            (1) in paragraph (14), by striking ``and'';
            (2) in paragraph (15) by striking the period at the end and 
        inserting ``; and''; and
            (3) by adding at the end the following:
            ``(16) $64,098,360 for the period beginning on October 1, 
        2023, and ending on December 31, 2023.''.

SEC. 2206. SMALL COMMUNITY AIR SERVICE.

    (a) Essential Air Service Authorization.--Section 41742(a)(2) of 
title 49, United States Code, is amended by striking ``2023'' and 
inserting ``2023, and $89,191,486 for the period beginning on October 
1, 2023, and ending on December 31, 2023,''.
    (b) Airports Not Receiving Sufficient Service.--Section 41743(e)(2) 
of title 49, United States Code, is amended by inserting ``, and 
$2,513,661 for the period beginning on October 1, 2023, and ending on 
December 31, 2023,'' after ``fiscal years 2018 through 2023''.

                Subtitle B--Aviation Revenue Provisions

SEC. 2211. EXPENDITURE AUTHORITY FROM AIRPORT AND AIRWAY TRUST FUND.

    (a) In General.--Section 9502(d)(1) of the Internal Revenue Code of 
1986 is amended--
            (1) in the matter preceding subparagraph (A) by striking 
        ``October 1, 2023'' and inserting ``January 1, 2024''; and
            (2) in subparagraph (A) by striking the semicolon at the 
        end and inserting ``or title II of division B of the Continuing 
        Appropriations Act, 2024 and Other Extensions Act;''.
    (b) Conforming Amendment.--Section 9502(e)(2) of such Code is 
amended by striking ``October 1, 2023'' and inserting ``January 1, 
2024''.

SEC. 2212. EXTENSION OF TAXES FUNDING AIRPORT AND AIRWAY TRUST FUND.

    (a) Fuel Taxes.--Section 4081(d)(2)(B) of the Internal Revenue Code 
of 1986 is amended by striking ``September 30, 2023'' and inserting 
``December 31, 2023''.
    (b) Ticket Taxes.--
            (1) Persons.--Section 4261(k)(1)(A)(ii) of such Code is 
        amended by striking ``September 30, 2023'' and inserting 
        ``December 31, 2023''.
            (2) Property.--Section 4271(d)(1)(A)(ii) of such Code is 
        amended by striking ``September 30, 2023'' and inserting 
        ``December 31, 2023''.
    (c) Fractional Ownership Programs.--
            (1) Fuel tax.--Section 4043(d) of such Code is amended by 
        striking ``September 30, 2023'' and inserting ``December 31, 
        2023''.
            (2) Treatment as noncommercial aviation.--Section 4083(b) 
        of such Code is amended by striking ``October 1, 2023'' and 
        inserting ``January 1, 2024''.
            (3) Exemption from ticket tax.--Section 4261(j) of such 
        Code is amended by striking ``September 30, 2023'' and 
        inserting ``December 31, 2023''.

              Subtitle C--Expiring Counter-UAS Authorities

SEC. 2221. PROTECTION OF CERTAIN FACILITIES AND ASSETS FROM UNMANNED 
              AIRCRAFT.

    Section 210G(i) of the Homeland Security Act of 2002 (6 U.S.C. 
124n(i)) is amended by striking ``on the date that is 4 years after the 
date of enactment of this section'' and inserting ``on November 18, 
2023''.

                  TITLE III--HEALTH AND HUMAN SERVICES

  Subtitle A--Animal Drug and Animal Generic Drug User Fee Amendments

                CHAPTER 1--FEES RELATING TO ANIMAL DRUGS

SEC. 2301. SHORT TITLE; FINDING.

    (a) Short Title.--This chapter may be cited as the ``Animal Drug 
User Fee Amendments of 2023''.
    (b) Finding.--Congress finds that the fees authorized by the 
amendments made in this chapter will be dedicated toward expediting the 
animal drug development process and the review of new and supplemental 
animal drug applications and investigational animal drug submissions as 
set forth in the goals identified for purposes of part 4 of subchapter 
C of chapter VII of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
379j-11 et seq.), in the letters from the Secretary of Health and Human 
Services to the Chairman of the Committee on Energy and Commerce of the 
House of Representatives and the Chairman of the Committee on Health, 
Education, Labor, and Pensions of the Senate as set forth in the 
Congressional Record.

SEC. 2302. DEFINITIONS.

    Section 739 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
379j-11) is amended--
            (1) in paragraph (3), by striking ``national drug code'' 
        and inserting ``National Drug Code''; and
            (2) by amending paragraph (8)(I) to read as follows:
                    ``(I) The activities necessary for implementation 
                of the United States and European Union Mutual 
                Recognition Agreement for Pharmaceutical Good 
                Manufacturing Practice Inspections, and the United 
                States and United Kingdom Mutual Recognition Agreement 
                Sectoral Annex for Pharmaceutical Good Manufacturing 
                Practices, and other mutual recognition agreements, 
                with respect to animal drug products subject to review, 
                including implementation activities prior to and 
                following product approval.''.

SEC. 2303. AUTHORITY TO ASSESS AND USE ANIMAL DRUG FEES.

    (a) In General.--Section 740(a)(1)(A)(ii) of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 379j- 12(a)(1)(A)(ii)) is amended--
            (1) in subclause (I), by striking ``and'' at the end;
            (2) in subclause (II), by striking the period at the end 
        and inserting ``; and''; and
            (3) by adding at the end the following:
                                    ``(III) an application for 
                                conditional approval under section 571 
                                of a new animal drug for which an 
                                animal drug application submitted under 
                                section 512(b)(1) has been previously 
                                approved under section 512(d)(1) for 
                                another intended use.''.
    (b) Fee Revenue Amounts.--Section 740(b)(1) of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 379j-12(b)(1)) is amended to read as 
follows:
            ``(1) In general.--Subject to subsections (c), (d), (f), 
        and (g), for each of fiscal years 2024 through 2028, the fees 
        required under subsection (a) shall be established to generate 
        a total revenue amount of $33,500,000.''.
    (c) Annual Fee Setting; Adjustments.--
            (1) Annual fee setting.--Section 740(c)(1) of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 379j-12(c)(1)) is 
        amended to read as follows:
            ``(1) Annual fee setting.--Not later than 60 days before 
        the start of each fiscal year beginning after September 30, 
        2023, the Secretary shall--
                    ``(A) establish for that fiscal year animal drug 
                application fees, supplemental animal drug application 
                fees, animal drug sponsor fees, animal drug 
                establishment fees, and animal drug product fees based 
                on the revenue amounts established under subsection (b) 
                and the adjustments provided under this subsection; and
                    ``(B) publish such fee revenue amounts and fees in 
                the Federal Register.''.
            (2) Inflation adjustment.--Section 740(c)(2) of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 379j-12(c)(2)) is 
        amended--
                    (A) in subparagraph (A)--
                            (i) in the matter preceding clause (i), by 
                        striking ``2020'' and inserting ``2025''; and
                            (ii) in clause (iii), by striking 
                        ``Baltimore'' and inserting ``Arlington-
                        Alexandria''; and
                    (B) in subparagraph (B), by striking ``2020'' and 
                inserting ``2025''.
            (3) Workload adjustments.--Section 740(c)(3) of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 379j-12(c)(3)) is 
        amended--
                    (A) in subparagraph (A)--
                            (i) in the matter preceding clause (i)--
                                    (I) by striking ``2020'' and 
                                inserting ``2025''; and
                                    (II) by striking ``subparagraphs 
                                (B) and (C)'' and inserting 
                                ``subparagraph (B)'';
                            (ii) in clause (i) by striking ``and'' at 
                        the end; and
                            (iii) by striking clause (ii) and inserting 
                        the following:
                            ``(ii) such adjustment shall be made for 
                        each fiscal year that the adjustment determined 
                        by the Secretary is greater than 3 percent, 
                        except for the first fiscal year that the 
                        adjustment is greater than 3 percent; and
                            ``(iii) the Secretary shall publish in the 
                        Federal Register notice under paragraph (1) the 
                        amount of such adjustment and the supporting 
                        methodologies.'';
                    (B) by striking subparagraph (B); and
                    (C) by redesignating subparagraph (C) as 
                subparagraph (B).
            (4) Final year adjustment.--Section 740(c)(4) of the 
        Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-12(c)(4)) 
        is amended to read as follows:
            ``(4) Operating reserve adjustment.--
                    ``(A) In general.--For fiscal year 2025 and each 
                subsequent fiscal year, after the fee revenue amount 
                established under subsection (b) is adjusted in 
                accordance with paragraphs (2) and (3), the Secretary 
                shall--
                            ``(i) increase the fee revenue amount for 
                        such fiscal year, if necessary to provide an 
                        operating reserve of not less than 12 weeks; or
                            ``(ii) if the Secretary has an operating 
                        reserve in excess of the number of weeks 
                        specified in subparagraph (C) for that fiscal 
                        year, the Secretary shall decrease the fee 
                        revenue amount to provide not more than the 
                        number of weeks specified in subparagraph (C) 
                        for that fiscal year.
                    ``(B) Carryover user fees.--For purposes of this 
                paragraph, the operating reserve of carryover user fees 
                for the process for the review of animal drug 
                applications does not include carryover user fees that 
                have not been appropriated.
                    ``(C) Number of weeks of operating reserves.--The 
                number of weeks of operating reserves specified in this 
                subparagraph is--
                            ``(i) 22 weeks for fiscal year 2025;
                            ``(ii) 20 weeks for fiscal year 2026;
                            ``(iii) 18 weeks for fiscal year 2027; and
                            ``(iv) 16 weeks for fiscal year 2028.
                    ``(D) Publication.--If an adjustment to the 
                operating reserve is made under this paragraph, the 
                Secretary shall publish in the Federal Register notice 
                under paragraph (1) the rationale for the amount of the 
                adjustment and the supporting methodologies.''.
    (d) Exemption From Fees.--Section 740(d)(4) of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 379j-12(d)(4)) is amended to read as 
follows:
            ``(4) Exemption from fees.--Fees under paragraphs (2), (3), 
        and (4) of subsection (a) shall not apply with respect to any 
        person who is the named applicant or sponsor of an animal drug 
        application, supplemental animal drug application, or 
        investigational animal drug submission if such application or 
        submission involves the intentional genomic alteration of an 
        animal that is intended to produce a drug, device, or 
        biological product subject to fees under section 736, 738, 
        744B, or 744H.''.
    (e) Crediting and Availability of Fees.--
            (1) Authorization of appropriations.--Section 740(g)(3) of 
        the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-
        12(g)(3)) is amended by striking ``2019 through 2023'' and 
        inserting ``2024 through 2028''.
            (2) Collection shortfalls.--Section 740(g) of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 379j-12(g)) is 
        amended--
                    (A) in paragraph (3), by striking ``and paragraph 
                (5)''; and
                    (B) by striking paragraph (5).

SEC. 2304. REAUTHORIZATION; REPORTING REQUIREMENTS.

    Section 740A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
379j-13) is amended--
            (1) in subsection (a), by striking ``2018'' and inserting 
        ``2023'';
            (2) by striking ``2019'' each place it appears in 
        subsections (a) and (b) and inserting ``2024''; and
            (3) in subsection (d)--
                    (A) in paragraph (1), by striking ``2023'' and 
                inserting ``2028''; and
                    (B) in paragraph (5), by striking ``2023'' and 
                inserting ``2028''.

SEC. 2305. SAVINGS CLAUSE.

    Notwithstanding the amendments made by this chapter, part 4 of 
subchapter C of chapter VII of the Federal Food, Drug, and Cosmetic Act 
(21 U.S.C. 379j-11 et seq.), as in effect on the day before the date of 
enactment of this chapter, shall continue to be in effect with respect 
to animal drug applications and supplemental animal drug applications 
(as defined in such part as of such day) that on or after October 1, 
2018, but before October 1, 2023, were accepted by the Food and Drug 
Administration for filing with respect to assessing and collecting any 
fee required by such part for a fiscal year prior to fiscal year 2024.

SEC. 2306. EFFECTIVE DATE.

    The amendments made by this chapter shall take effect on October 1, 
2023, or the date of the enactment of this Act, whichever is later, 
except that fees under part 4 of subchapter C of chapter VII of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-11 et seq.), as 
amended by this chapter, shall be assessed for animal drug applications 
and supplemental animal drug applications received on or after October 
1, 2023, regardless of the date of the enactment of this Act.

SEC. 2307. SUNSET DATES.

    (a) Authorization.--Sections 739 and 740 of the Federal Food, Drug, 
and Cosmetic Act (21 U.S.C. 21 U.S.C. 379j-11; 379j-12) shall cease to 
be effective October 1, 2028.
    (b) Reporting Requirements.--Section 740A of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 379j-13) shall cease to be effective 
January 31, 2029.
    (c) Previous Sunset Provision.--Effective October 1, 2023, 
subsections (a) and (b) of section 107 of the Animal Drug User Fee 
Amendments of 2018 (Public Law 115-234) are repealed.

            CHAPTER 2--FEES RELATING TO GENERIC ANIMAL DRUGS

SEC. 2311. SHORT TITLE; FINDING.

    (a) Short Title.--This chapter may be cited as the ``Animal Generic 
Drug User Fee Amendments of 2023''.
    (b) Finding.--Congress finds that the fees authorized by the 
amendments made in this chapter will be dedicated toward expediting the 
generic new animal drug development process and the review of 
abbreviated applications for generic new animal drugs, supplemental 
abbreviated applications for generic new animal drugs, and 
investigational submissions for generic new animal drugs as set forth 
in the goals identified for purposes of part 5 of subchapter C of 
chapter VII of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
379j-21 et seq.), in the letters from the Secretary of Health and Human 
Services to the Chairman of the Committee on Energy and Commerce of the 
House of Representatives and the Chairman of the Committee on Health, 
Education, Labor, and Pensions of the Senate as set forth in the 
Congressional Record.

SEC. 2312. AUTHORITY TO ASSESS AND USE GENERIC NEW ANIMAL DRUG FEES.

    (a) Generic Investigational New Animal Drug File Fee.--Section 
741(a) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-
21(a)) is amended by adding at the end the following:
            ``(4) Generic investigational new animal drug file fee.--
                    ``(A) In general.--
                            ``(i) New file request.--Each person that 
                        submits a request to establish a generic 
                        investigational new animal drug file on or 
                        after October 1, 2023, shall be assessed a fee 
                        as established under subsection (c).
                            ``(ii) New submission to established 
                        file.--Each person that makes a submission to a 
                        generic investigational new animal drug file on 
                        or after October 1, 2023, where such file was 
                        established prior to October 1, 2023, shall be 
                        assessed a fee for the first submission on or 
                        after October 1, 2023, as established under 
                        subsection (c).
                    ``(B) Payment.--
                            ``(i) New file request.--The fee required 
                        by subparagraph (A)(i) shall be due upon 
                        submission of the request to establish the 
                        generic investigational new animal drug file.
                            ``(ii) New submission to established 
                        file.--The fee required by subparagraph (A)(ii) 
                        shall be due upon the first submission to the 
                        generic investigational new animal drug file.
                    ``(C) Exceptions.--
                            ``(i) Terminating an existing generic 
                        investigational new animal drug file.--If a 
                        person makes a submission to the generic 
                        investigational new animal drug file to 
                        terminate that file, the person shall not be 
                        subject to a fee under subparagraph (A)(ii) for 
                        that submission.
                            ``(ii) Transferring an existing generic 
                        investigational new animal drug file.--If a 
                        person makes a submission to the generic 
                        investigational new animal drug file to 
                        transfer that file to a different generic new 
                        animal drug sponsor, the person shall not be 
                        subject to a fee under subparagraph (A)(ii) for 
                        that submission.''.
    (b) Fee Revenue Amounts.--Section 741(b) of the Federal Food, Drug, 
and Cosmetic Act (21 U.S.C. 379j- 21(b)) is amended--
            (1) in paragraph (1)--
                    (A) by striking ``2019 through 2023'' and inserting 
                ``2024 through 2028''; and
                    (B) by striking ``$18,336,340'' and inserting 
                ``$25,000,000''; and
            (2) in paragraph (2)--
                    (A) in subparagraph (A)--
                            (i) by striking ``25 percent'' and 
                        inserting ``20 percent''; and
                            (ii) by inserting before the semicolon at 
                        the end the following: ``and fees under 
                        subsection (a)(4) (relating to generic 
                        investigational new animal drug files)'';
                    (B) in subparagraph (B), by striking ``37.5 
                percent'' and inserting ``40 percent''; and
                    (C) in subparagraph (C), by striking ``37.5 
                percent'' and inserting ``40 percent''.
    (c) Annual Fee Setting; Adjustments.--
            (1) Annual fee setting.--Section 741(c)(1) of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 379j-21(c)(1)) is 
        amended to read as follows:
            ``(1) Annual fee setting.--The Secretary shall establish, 
        not later than 60 days before the start of each fiscal year 
        beginning after September 30, 2023, for that fiscal year--
                    ``(A) abbreviated application fees that are based 
                on the revenue amounts established under subsection 
                (b), the adjustments provided under this subsection, 
                and the amount of fees anticipated to be collected 
                under subsection (a)(4) during that fiscal year;
                    ``(B) generic new animal drug sponsor fees, and 
                generic new animal drug product fees, based on the 
                revenue amounts established under subsection (b) and 
                the adjustments provided under this subsection; and
                    ``(C) a generic investigational new animal drug 
                file fee of $50,000 for each request or submission 
                described in subsection (a)(4)(A).''.
            (2) Inflation adjustment.--Section 741(c)(2) of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 379j-21(c)(2)) is 
        amended--
                    (A) in subparagraph (A)--
                            (i) in the matter preceding clause (i), by 
                        striking ``2020'' and inserting ``2025''; and
                            (ii) in clause (iii), by striking 
                        ``Baltimore'' and inserting ``Arlington-
                        Alexandria''; and
                    (B) in subparagraph (B), by striking ``2020'' and 
                inserting ``2025''.
            (3) Workload adjustment.--Section 741(c)(3) of the Federal 
        Food, Drug, and Cosmetic Act (21 U.S.C. 379j-21(c)(3)) is 
        amended--
                    (A) in subparagraph (A)--
                            (i) in the matter preceding clause (i), by 
                        striking ``2020'' and inserting ``2025'';
                            (ii) in clause (i)--
                                    (I) by striking ``and 
                                investigational generic new animal drug 
                                protocol submissions'' and inserting 
                                ``investigational generic new animal 
                                drug protocol submissions, requests to 
                                establish a generic investigational new 
                                animal drug file, and generic 
                                investigational new animal drug meeting 
                                requests''; and
                                    (II) by striking ``; and'' and 
                                inserting a semicolon;
                            (iii) by redesignating clause (ii) as 
                        clause (iii); and
                            (iv) by inserting after clause (i) the 
                        following:
                            ``(ii) if the workload adjustment 
                        calculated by the Secretary under clause (i) 
                        exceeds 25 percent, the Secretary shall use 25 
                        percent for the adjustment; and''; and
                    (B) in subparagraph (B), by striking ``2021 through 
                2023'' and inserting ``2026 through 2028''.
            (4) Final year adjustment.--Section 741(c)(4) of the 
        Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-21(c)(4)) 
        is amended--
                    (A) by striking ``2023'' each place it appears and 
                inserting ``2028''; and
                    (B) by striking ``2024'' and inserting ``2029''.
    (d) Fee Waiver or Reduction; Exemption From Fees.--Subsection (d) 
of section 741 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
379j-21) is amended to read as follows:
    ``(d) Fee Waiver or Reduction.--The Secretary shall grant a waiver 
from, or a reduction of, one or more fees assessed under subsection (a) 
where the Secretary finds that the generic new animal drug is intended 
solely to provide for a minor use or minor species indication.''.
    (e) Effect of Failure to Pay Fees.--Section 741(e) of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 379j-21(e)) is amended by 
striking ``The Secretary may discontinue'' and inserting ``A request to 
establish a generic investigational new animal drug file that is 
submitted by a person subject to fees under subsection (a) shall be 
considered incomplete and shall not be accepted for action by the 
Secretary until all fees owed by such person have been paid. The 
Secretary may discontinue''.
    (f) Assessment of Fees.--Section 741(f)(2) of the Federal Food, 
Drug, and Cosmetic Act (21 U.S.C. 379j- 21(f)(2)) is amended by 
striking ``sponsors, and generic new animal drug products at any time'' 
and inserting ``products, generic new animal drug sponsors, and generic 
investigational new animal drug files at any time''.
    (g) Crediting and Availability of Fees.--Section 741(g) of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-21(g)) is 
amended--
            (1) in paragraph (3), by striking ``2019 through 2023'' and 
        inserting ``2024 through 2028'';
            (2) by striking the second paragraph (4) (relating to 
        Offset), as added by section 202 of the Animal Generic Drug 
        User Fee Amendments of 2013 (Public Law 113-14); and
            (3) by adding at the end the following:
            ``(5) Recovery of collection shortfalls.--The amount of 
        fees otherwise authorized to be collected under this section 
        shall be increased--
                    ``(A) for fiscal year 2026, by the amount, if any, 
                by which the amount collected under this section and 
                appropriated for fiscal year 2024 falls below the 
                amount of fees authorized for fiscal year 2024 under 
                paragraph (3);
                    ``(B) for fiscal year 2027, by the amount, if any, 
                by which the amount collected under this section and 
                appropriated for fiscal year 2025 falls below the 
                amount of fees authorized for fiscal year 2025 under 
                paragraph (3); and
                    ``(C) for fiscal year 2028, by the amount, if any, 
                by which the amount collected under this section and 
                appropriated for fiscal years 2026 and 2027 (including 
                estimated collections for fiscal year 2027) falls below 
                the amount of fees authorized for such fiscal years 
                under paragraph (3).''.
    (h) Definitions.--Section 741(k) of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 379j-21(k)) is amended--
            (1) by redesignating paragraphs (8), (9), (10), and (11) as 
        paragraphs (9), (10), (11), and (13), respectively;
            (2) by inserting after paragraph (7) the following:
            ``(8) Generic investigational new animal drug meeting 
        request.--The term `generic investigational new animal drug 
        meeting request' means a request submitted by a generic new 
        animal drug sponsor to meet with the Secretary to discuss an 
        investigational submission for a generic new animal drug.'';
            (3) in paragraph (11) (as so redesignated), by adding at 
        the end the following:
                    ``(I) The activities necessary for exploration and 
                implementation of the United States and European Union 
                Mutual Recognition Agreement for Pharmaceutical Good 
                Manufacturing Practice Inspections, and the United 
                States and United Kingdom Mutual Recognition Agreement 
                Sectoral Annex for Pharmaceutical Good Manufacturing 
                Practices, and other mutual recognition agreements, 
                with respect to generic new animal drug products 
                subject to review, including implementation activities 
                prior to and following product approval.''; and
            (4) by inserting after paragraph (11) (as so redesignated) 
        the following:
            ``(12) Request to establish a generic investigational new 
        animal drug file.--The term `request to establish a generic 
        investigational new animal drug file' means the submission to 
        the Secretary of a request to establish a generic 
        investigational new animal drug file to contain investigational 
        submissions for a generic new animal drug.''.

SEC. 2313. REAUTHORIZATION; REPORTING REQUIREMENTS.

    Section 742 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
379j-22) is amended--
            (1) in subsection (a), by striking ``2018'' and inserting 
        ``2023'';
            (2) by striking ``2019'' each place it appears in 
        subsections (a) and (b) and inserting ``2024''; and
            (3) in subsection (d), by striking ``2023'' each place it 
        appears and inserting ``2028''.

SEC. 2314. SAVINGS CLAUSE.

    Notwithstanding the amendments made by this chapter, part 5 of 
subchapter C of chapter VII of the Federal Food, Drug, and Cosmetic Act 
(21 U.S.C. 379j-21 et seq.), as in effect on the day before the date of 
enactment of this chapter, shall continue to be in effect with respect 
to abbreviated applications for a generic new animal drug and 
supplemental abbreviated applications for a generic new animal drug (as 
defined in such part as of such day) that on or after October 1, 2018, 
but before October 1, 2023, were accepted by the Food and Drug 
Administration for filing with respect to assessing and collecting any 
fee required by such part for a fiscal year prior to fiscal year 2024.

SEC. 2315. EFFECTIVE DATE.

    The amendments made by this chapter shall take effect on October 1, 
2023, or the date of the enactment of this Act, whichever is later, 
except that fees under part 5 of subchapter C of chapter VII of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-21 et seq.), as 
amended by this chapter, shall be assessed for abbreviated applications 
for a generic new animal drug and supplemental abbreviated applications 
for a generic new animal drug received on or after October 1, 2023, 
regardless of the date of enactment of this Act.

SEC. 2316. SUNSET DATES.

    (a) Authorization.--Section 741 of the Federal Food, Drug, and 
Cosmetic Act (21 U.S.C. 379j-21) shall cease to be effective October 1, 
2028.
    (b) Reporting Requirements.--Section 742 of the Federal Food, Drug, 
and Cosmetic Act (21 U.S.C. 379j- 22) shall cease to be effective 
January 31, 2029.
    (c) Previous Sunset Provision.--Effective October 1, 2023, 
subsections (a) and (b) of section 206 of the Animal Generic Drug User 
Fee Amendments of 2018 (Public Law 115-234) are repealed.

                  Subtitle B--Public Health Extenders

SEC. 2321. EXTENSION FOR COMMUNITY HEALTH CENTERS, NATIONAL HEALTH 
              SERVICE CORPS, AND TEACHING HEALTH CENTERS THAT OPERATE 
              GME PROGRAMS.

    (a) Teaching Health Centers That Operate Graduate Medical Education 
Programs.--Section 340H(g) of the Public Health Service Act (42 U.S.C. 
256h(g)) is amended--
            (1) by striking ``and $126,500,000'' and inserting 
        ``$126,500,000''; and
            (2) by inserting ``and $16,635,616 for the period beginning 
        on October 1, 2023, and ending on November 17, 2023,'' before 
        ``to remain available''.
    (b) Extension for Community Health Centers.--Section 10503(b)(1)(F) 
of the Patient Protection and Affordable Care Act (42 U.S.C. 254b-
2(b)(1)(F)) is amended--
            (1) by striking ``and $4,000,000,000'' and inserting ``, 
        $4,000,000,000''; and
            (2) by inserting ``, and $526,027,397 for the period 
        beginning on October 1, 2023, and ending on November 17, 2023'' 
        before the semicolon.
    (c) Extension for the National Health Service Corps.--Section 
10503(b)(2) of the Patient Protection and Affordable Care Act (42 
U.S.C. 254b-2(b)(2)) is amended--
            (1) in subparagraph (G), by striking ``and'' at the end;
            (2) in subparagraph (H), by striking the period at the end 
        and inserting ``; and''; and
            (3) by adding at the end the following:
                    ``(I) $40,767,123 for the period beginning on 
                October 1, 2023, and ending on November 17, 2023.''.
    (d) Application of Provisions.--Amounts appropriated pursuant to 
the amendments made by this section shall be subject to the 
requirements contained in Public Law 117-328 for funds for programs 
authorized under sections 330 through 340 of the Public Health Service 
Act (42 U.S.C. 254b et seq.).
    (e) Technical and Conforming Amendment.--Section 3014(h)(4) of 
title 18, United States Code, is amended--
            (1) by striking ``Other Extensions Act,,'' and inserting 
        ``Other Extensions Act,''; and
            (2) by striking ``and section 301(d) of division BB of the 
        Consolidated Appropriations Act, 2021.'' and inserting 
        ``section 301(d) of division BB of the Consolidated 
        Appropriations Act, 2021, and section 2321(d) of the Continuing 
        Appropriations Act, 2024 and Other Extensions Act''.

SEC. 2322. EXTENSION OF SPECIAL DIABETES PROGRAMS.

    (a) Extension of Special Diabetes Programs for Type I Diabetes.--
Section 330B(b)(2) of the Public Health Service Act (42 U.S.C. 254c-
2(b)(2)) is amended--
            (1) in subparagraph (C), by striking ``and'' at the end;
            (2) in subparagraph (D), by striking the period and 
        inserting ``; and''; and
            (3) by adding at the end the following:
                    ``(E) $19,726,027 for the period beginning on 
                October 1, 2023, and ending on November 17, 2023, to 
                remain available until expended.''.
    (b) Extending Funding for Special Diabetes Programs for Indians.--
Section 330C(c)(2) of the Public Health Service Act (42 U.S.C. 254c-
3(c)(2)) is amended--
            (1) in subparagraph (C), by striking ``and'' at the end;
            (2) in subparagraph (D), by striking the period and 
        inserting ``; and''; and
            (3) by adding at the end the following:
                    ``(E) $19,726,027 for the period beginning on 
                October 1, 2023, and ending on November 17, 2023, to 
                remain available until expended.''.

        Subtitle C--Necessary Authorities To Respond to Threats

SEC. 2331. EXTENSION OF AUTHORITY TO MAKE CERTAIN APPOINTMENTS OF 
              NATIONAL DISASTER MEDICAL SYSTEM PERSONNEL.

    Section 2812(c)(4)(B) of the Public Health Service Act (42 U.S.C. 
300hh-11(c)(4)(B)) is amended by striking ``September 30, 2023'' and 
inserting ``November 17, 2023''.

SEC. 2332. TEMPORARY REASSIGNMENT OF STATE AND LOCAL PERSONNEL DURING A 
              PUBLIC HEALTH EMERGENCY.

    Section 319(e)(8) of the Public Health Service Act (42 U.S.C. 
247d(e)(8)) is amended by striking ``September 30, 2023'' and inserting 
``November 17, 2023''.

SEC. 2333. EXTENSION OF NATIONAL ADVISORY COMMITTEES.

    (a) National Advisory Committee on Children and Disasters.--Section 
2811A(g) of the Public Health Service Act (42 U.S.C. 300hh-10b(g)) is 
amended by striking ``September 30, 2023'' and inserting ``November 17, 
2023''.
    (b) National Advisory Committee on Seniors and Disasters.--Section 
2811B(g)(1) of the Public Health Service Act (42 U.S.C. 300hh-
10c(g)(1)) is amended by striking ``September 30, 2023'' and inserting 
``November 17, 2023''.
    (c) National Advisory Committee on Individuals With Disabilities 
and Disasters.--Section 2811C(g)(1) of the Public Health Service Act 
(42 U.S.C. 300hh-10d(g)(1)) is amended by striking ``September 30, 
2023'' and inserting ``November 17, 2023''.

                          Subtitle D--Medicaid

SEC. 2341. DSH DELAY.

    Section 1923(f)(7)(A) of the Social Security Act (42 U.S.C. 1396r-
4(f)(7)(A)) is amended--
            (1) in clause (i)--
                    (A) in the matter preceding subclause (I), by 
                striking ``For each of fiscal years 2024 through 2027'' 
                and inserting ``For the period beginning November 18, 
                2023, and ending September 30, 2024, and for each of 
                fiscal years 2025 through 2027''; and
                    (B) in subclauses (I) and (II), by inserting ``or 
                period'' after ``the fiscal year'' each place it 
                appears; and
            (2) in clause (ii), by striking ``for each of fiscal years 
        2024 through 2027'' and inserting ``for the period beginning 
        November 18, 2023, and ending September 30, 2024, and for each 
        of fiscal years 2025 through 2027.''.

SEC. 2342. MIF REDUCTION.

    Section 1941(b)(3)(A) of the Social Security Act (42 U.S.C. 1396w-
1(b)(3)(A)) is amended by striking ``$7,000,000,000'' and inserting 
``$6,357,117,810''.

                       Subtitle E--Human Services

SEC. 2351. EXTENSION OF CHILD AND FAMILY SERVICES PROGRAMS.

    Activities authorized by part B of title IV of the Social Security 
Act shall continue through November 17, 2023, in the manner authorized 
for fiscal year 2023, and out of any money in the Treasury of the 
United States not otherwise appropriated, there are hereby appropriated 
such sums as may be necessary for such purpose.

SEC. 2352. SEXUAL RISK AVOIDANCE EDUCATION EXTENSION.

    Section 510 of the Social Security Act (42 U.S.C. 710) is amended--
            (1) in subsection (a)--
                    (A) in paragraph (1)--
                            (i) in the matter preceding subparagraph 
                        (A)--
                                    (I) by inserting ``and for the 
                                period beginning on October 1, 2023, 
                                and ending on November 17, 2023'' after 
                                ``2023''; and
                                    (II) by inserting ``(or, with 
                                respect to such period, for fiscal year 
                                2024)'' after ``for the fiscal year''; 
                                and
                            (ii) in subparagraph (A), by inserting ``or 
                        period'' after ``fiscal year'' each place it 
                        appears; and
                    (B) in paragraph (2)--
                            (i) in subparagraph (A), by inserting ``and 
                        with respect to fiscal year 2024, for the 
                        period described in paragraph (1)'' after 
                        ``2023''; and
                            (ii) in subparagraph (B)(i), by inserting 
                        ``(or, with respect to fiscal year 2024, for 
                        the period described in paragraph (1))'' after 
                        ``for the fiscal year''; and
            (2) in subsection (f)--
                    (A) in paragraph (1), by inserting ``, and for the 
                period beginning on October 1, 2023, and ending on 
                November 17, 2023, an amount equal to the pro rata 
                portion of the amount appropriated for the 
                corresponding period for fiscal year 2023'' after 
                ``2023''; and
                    (B) in paragraph (2), by inserting ``and for the 
                period described in paragraph (1),'' after ``2023,''.

SEC. 2353. PERSONAL RESPONSIBILITY EDUCATION EXTENSION.

    Section 513 of the Social Security Act (42 U.S.C. 713) is amended--
            (1) in subsection (a)--
                    (A) in paragraph (1)--
                            (i) in subparagraph (A)--
                                    (I) in the matter preceding clause 
                                (i), by inserting ``and for the period 
                                beginning on October 1, 2023, and 
                                ending on November 17, 2023'' after 
                                ``2023''; and
                                    (II) in clause (i), by inserting 
                                ``or period'' after ``for the fiscal 
                                year'';
                            (ii) in subparagraph (B)(i), by inserting 
                        the following after the period: ``The previous 
                        sentence shall not apply with respect to State 
                        allotments under this paragraph for the period 
                        beginning on October 1, 2023, and ending on 
                        November 17, 2023.''; and
                            (iii) in subparagraph (C)(i)--
                                    (I) by inserting ``or the period 
                                described in subparagraph (A)'' after 
                                ``for a fiscal year''; and
                                    (II) by inserting ``or period'' 
                                after ``the fiscal year'';
                    (B) in paragraph (3)--
                            (i) by inserting ``or the period described 
                        in paragraph (1)(A)'' after ``for a fiscal 
                        year''; and
                            (ii) by inserting ``or period'' after 
                        ``such fiscal year''; and
                    (C) in paragraph (4)--
                            (i) by inserting ``and for the period 
                        described in paragraph (1)(A)'' after ``fiscal 
                        years 2010 through 2023'';
                            (ii) by inserting ``and for the period so 
                        described'' after ``fiscal years 2012 through 
                        2023''; and
                            (iii) by inserting ``or the period so 
                        described'' after ``for a fiscal year'';
            (2) in subsection (c)--
                    (A) in each of paragraphs (1) and (2), by striking 
                ``From'' and inserting ``Subject to paragraph (3), 
                from''; and
                    (B) by adding at the end the following:
            ``(3) Exception.--Paragraphs (1) and (2) shall not apply 
        with respect to any amount appropriated under subsection (f) 
        for the period described in subsection (a)(1)(A).''; and
            (3) in subsection (f), by inserting ``, and for the period 
        beginning on October 1, 2023, and ending on November 17, 2023, 
        an amount equal to the pro rata portion of the amount 
        appropriated for the corresponding period for fiscal year 
        2023'' after ``2023''.

                      TITLE IV--BUDGETARY EFFECTS

SEC. 2401. BUDGETARY EFFECTS.

    (a) Statutory Paygo Scorecards.--The budgetary effects of this 
division shall not be entered on either PAYGO scorecard maintained 
pursuant to section 4(d) of the Statutory Pay-As-You-Go Act of 2010.
    (b) Senate Paygo Scorecards.--The budgetary effects of this 
division shall not be entered on any PAYGO scorecard maintained for 
purposes of section 4106 of H. Con. Res. 71 (115th Congress).
    (c) Classification of Budgetary Effects.--Notwithstanding Rule 3 of 
the Budget Scorekeeping Guidelines set forth in the joint explanatory 
statement of the committee of conference accompanying Conference Report 
105-217 and section 250(c)(8) of the Balanced Budget and Emergency 
Deficit Control Act of 1985, the budgetary effects of this division 
shall not be estimated--
            (1) for purposes of section 251 of such Act;
            (2) for purposes of an allocation to the Committee on 
        Appropriations pursuant to section 302(a) of the Congressional 
        Budget Act of 1974; and
            (3) for purposes of paragraph (4)(C) of section 3 of the 
        Statutory Pay-As-You-Go Act of 2010 as being included in an 
        appropriation Act.

            Passed the House of Representatives September 30, 2023.

            Attest:

                                             KEVIN F. MCCUMBER,

                                                                 Clerk.